WHERE DO WE GO FROM HERE? BEYOND THE NEJM MAGNASAFE TRIAL: A FOCUS BEYOND A MYOPIC CMR ‘SAFETY-FIRST’ NOTION

Authors :: Loretta Gevenosky
Ronald B Williams
Robert W Biederman
Huma Samar
Mark Doyle
Christopher Bonnet
Moneal Shah
Richard Lombardi
Source :: Journal of the American College of Cardiology. 71:A487
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.
Abstract: Today, MRI is infrequently performed in pts with conventional PM/lCDs. While MagnaSafe, published in NEJM for non-thoracic MRI, unequivocally documented safety, the clinical value remains unconsidered. A myopic, potentially prohibitive, focus on safety continues. MRI in PM/lCDs pts is crucial to

Subjects :: Focus (computing)
medicine.medical_specialty
business.industry
Clinical value
Medicine
Safety first
Medical physics
macromolecular substances
Cardiology and Cardiovascular Medicine
business

Tools